RESISTELL AG
RESISTELL AG
Industry:
Medical Device
Founded:
2018-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Total Employee:
1+
Status:
Active
Contact:
+41 79 899 91 88
Total Funding:
7.32 M USD
Similar Organizations
Clemedi
Clemedi provides antibiotic resistance testing.
Dxcover
The Future of Cancer Diagnostics
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Pfizer
Pfizer investment in Grant - Resistell AG
European Innovation Council
European Innovation Council investment in Grant - Resistell AG
OCCIDENT
OCCIDENT investment in Series A - Resistell AG
Alpana Ventures
Alpana Ventures investment in Series A - Resistell AG
Hemex
Hemex investment in Series A - Resistell AG
TRUMPF Venture
TRUMPF Venture investment in Series A - Resistell AG
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - Resistell AG
OCCIDENT
OCCIDENT investment in Seed Round - Resistell AG
Hemex
Hemex investment in Seed Round - Resistell AG
Venture Kick
Venture Kick investment in Seed Round - Resistell AG
Newest Events participated
More informations about "Resistell AG"
Resistell | The fastest and most extensible Antibiotic Susceptibility ...
Welcome to Resistell, where we harness cutting-edge nanomotion technology to provide the fastest, most accurate ultra-rapid antibiotic susceptibility tests available. Discover how our solutions are setting new standards in healthcare, enhancing patient outcomes, and combating …See details»
Resistell AG - Crunchbase Company Profile & Funding
Resistell AG is located in Basel, Basel-Stadt, Switzerland. Who invested in Resistell AG? Resistell AG has 10 investors including TRUMPF Venture and Launchpad. How much funding has Resistell AG raised to date? Resistell AG …See details»
Resistell AG - Swiss Biotech
Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST is based on …See details»
Resistell Company Profile 2024: Valuation, Funding & Investors
Developer of a proprietary, growth-independent, phenotypic Antibiotic Susceptibility Testing (AST) platform designed to provide rapid diagnostic results.See details»
Resistell AG Company Profile: Overview and Full News Analysis
Resistell AG, based in Basel-Stadt, is a company at the forefront of developing a leading Rapid Antibiotic Susceptibility Testing (AST) solution. Their innovative approach is based on a first-in …See details»
Resistell AG - Funding, Financials, Valuation & Investors
Resistell AG is funded by 10 investors. TRUMPF Venture and Launchpad are the most recent investors. in funding over 9 rounds. Their latest funding was raised on Dec 20, 2022 from a …See details»
News: Investors give Resistell 8.5 million Swiss francs
Dec 23, 2022 · Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology company plans to use this to gain European certification for its test device, which uses nanotechnology to …See details»
Resistell AG - top100startup.ch
Jun 9, 2023 · Resistell AG: Resistell is revolutionizing Antibiotic Susceptibility Testing (AST) with the world’s fastest platform. Our CE IVD-certified AST for bloodstream infections has been validated in two clinical studies with over 500 …See details»
Resistell AG announces start of Performance Evaluation …
Jun 16, 2021 · Resistell AG, the start-up developing the world’s fastest phenotypic Antibiotic Susceptibility Test (AST), has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne University …See details»
Resistell initiates a research project funded by an …
Apr 20, 2022 · Resistell, a TOP10 Swiss Start-up addressing the problem of speed in the diagnostics of antibiotic resistance, is pleased to announce they have initiated a research project to assess the applicability of Resistell’s …See details»
Resistell raises CHF 8.5 million to complete clinical trials for ...
Dec 19, 2022 · Resistell raised CHF 8.5 million from investors, including EIC Fund, TRUMPF Venture, OCCIDENT, Zürcher Kantonalbank, Launchpad, and private investors. The company …See details»
Nanomotion technology for ultrarapid antibiotic susceptibility …
Oct 4, 2023 · Resistell’s expertise extends beyond AST for Gram-negative and Gram-positive pathogens. The nanomotion technology offers advantages for assessing resistance and …See details»
Resistell AG closes its series B first tranche of CHF 8.5m
Dec 19, 2022 · Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, has taken another major step to achieving its vision by closing a first tranche of its series …See details»
Resistell AG closes its series B first tranche of CHF 8.5 Million
Nov 12, 2024 · Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, has taken another major step to achieving its vision by closing a first tranche of its series …See details»
Accurate and rapid antibiotic susceptibility testing using a machine ...
Mar 18, 2024 · Antimicrobial resistance (AMR) is a major public health threat, reducing treatment options for infected patients. AMR is promoted by a lack of access to rapid antibiotic …See details»
Resistell raises CHF 8.5 million to complete clinical trials for ...
Dec 22, 2022 · Resistell AG closed a first tranche of its Series B financing round with CHF 8.5 million raised from new and existing investors. The startup is a leader in phenotypic …See details»
Rapid diagnostic for bacterial SEPSIS and AMR urgently needed …
Feb 26, 2023 · The current standard antibiotic susceptibility testing (AST) takes too long to be efficient in sepsis cases. Swiss Resistell AG developed a breakthrough AST technology that …See details»
Investigating nanomotion-based technology (Resistell AST) for …
The Resistell AST is based on a new technology measuring the nanomotion caused by physiologically active bacterial cells and detecting the changes in nanomotion caused by the …See details»
Latest News on Antibiotic Resistance and AST Innovations | Resistell
Stay informed with the latest developments in antibiotic susceptibility testing and the global fight against antimicrobial resistance. Explore breaking news, insights, and updates from Resistell, …See details»
The Global Health Crisis and its Impact - Resistell
Antimicrobial resistance (AMR) is a crisis that threatens global health by making infections harder to treat and increasing mortality rates. Learn how Resistell’s ultra-rapid AST technology offers …See details»